Features of arterial hypertension course in patients with psoriasis
DOI:
https://doi.org/10.14739/2310-1210.2017.2.95559Keywords:
arterial hypertension, essential hypertension, psoriasisAbstract
Risk of cardiovascular and cerebrovascular events development in psoriasis patients is higher than in population as a whole. Combination of arterial hypertension and psoriasis is widespread and understudied state, thus the objective of our work was to reveal features of this comorbid pathology formation and course.
Material and Methods. For the implementation of the set task specific features of clinical picture of arterial hypertension (presented by essential hypertension) and psoriasis were studied. Two groups of patients included 47 persons suffering from essential hypertension and 98 persons suffering from psoriasis and essential hypertension simultaneously. Dermatosis course severity was estimated clinically using PASI index, 24-hour blood pressure index was determined by means of 24-hour blood pressure monitoring. Levels of cytokines, cortisol, and insulin were determined by immunoenzymatic methods.
Results. As the result it was revealed that patients with comorbid pathology have severe and moderate degree of arterial hypertension more often than in case of arterial hypertension without dermatosis (95 % vs. 85 %). In this group of patients the specific feature of blood pressure circadian rhythm was revealed in form of its insufficient decrease in the evening and at night (non-dipper and night-peaker groups); total number of such patients made 63.64 %. Levels of cytokines (IL-β,IL-1α, IL-6, TNF-α) in the group with comorbid pathology greatly exceed the similar indices of patients without dermatosis. This fact can be explained by available severe form of psoriasis (exudative, arthropica) with expressed systemic inflammatory reactions. Interleukins levels critically increased in patients with the 3 degree of arterial hypertension in case of combined pathology. It has been found that duration of disease especially in case of psoriasis and arterial hypertension severe form combination had negative influence on adaptive mechanisms. This fact was confirmed by considerable decreasing in cortisol level (difference made 39.74 % in favor of patients with the 1–2 degree of arterial hypertension) and increasing of insulin in blood (difference made 31.91 % in favor of patients with the 1–2 degree of hypertension in case of comorbid pathology).
Conclusions. Thus, psoriasis and arterial hypertension combination creates conditions for the systemic inflammatory process formation with prominent clinical manifestations of both dermatosis and hypertension, specific features of blood pressure circadian rhythm, chronic stress and decompensation formation in case of long course of disease and hypertension severe form development.
References
Syzon, O. O., & Stepanenko, V. I. (2014) Kontrol za rozvytkom ta perebihom suputnoi patolohii u khvorykh na artropatychnyi psoriaz [Control for development and course of concomitant pathology in patients with psoriasis arthropica]. Ukrainskyi zhurnal dermatologіi, venerologіi, kosmetologіi, 2(53), 13–24. [in Ukrainian].
Kvershi, A. A., Choy, Kh. K., Setti, A. P., & Kurhan, G. S. (2010) Psoriaz i risk razvitiya diabeta i gipertenzii [Psoriasis and risk of diabetes and hypertension development]. Rossijskij medicinskij zhurnal, 12, 765. [in Russian].
Boehncke, W. H., Boehncke, S., Tobin, A. M., & Kirby, B. (2011) The ‘psoriatic march’: a concept of how severe psoriasis may drive cardiovascular. Exp. Dermatol, 20, 303–307. doi: 10.1111/j.1600-0625.2011.01261.x.
Dovzhanskij, S. I., & Uts, S. R. (1992) Psoriaz ili psoriaticheskaya bolezn´. [Psoriasis or psoriatic disease]. Saratov. [in Russian].
Herédi, E., Végh, J., Pogácsás, L., Gáspár, K., Varga, J., Kincse, G., et al. (2016) Subclinical cardiovascular disease and it's improvement after long-term TNF-α inhibitor therapy in severe psoriatic. J Eur Acad Dermatol Venereol, 9. doi: 10.1111/jdv.13649.
Horreau, C., Pouplard, C., Brenaut, E., Barnetche, T., Misery, L., Cribier, B., et al. (2013) Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: a systematic literature review. J. Eur. Acad. Dermatol. Venerel., 3, 12–29. doi: 10.1111/jdv.12163.
McDonald, I., Connolly, M., & Tobin, A. M. (2012) Review of psoriasis, a known risk factor for cardiovascular disease and its impact on folate and homocysteine metabolism. Journal of Nutrition and Metabolism, 2012, 965385. doi: 10.1155/2012/965385.
Shrivastava, V. K., Londhe, N. D., Sonawane, R. S., & Suri, J. S. (2015) Exploring the color feature power for psoriasis risk stratification and classification: A data mining paradigm. Comput Biol Med., 65, 54–68. doi: 10.1016/j.compbiomed.2015.07.021.
Stern, R. (2010) Psoriasis is not usefull independent risk factor for cardiovascular disease. J.I.D, 130, 917–919. doi: 10.1038/jid.2009.446.
Cyganok, S. S. (1997) Cerebrokardial´nye narusheniya i ikh korrekciya u bol´nykh psoriazom [Cerebrocardial disorders and their correction in psoriasis patients]. Vestnik dermatologii i venerologii, 2, 27–30. [in Russian].
Polachek, A., Touma, Z., Anderson, M., & Eder, L. (2017) Risk of Cardiovascular Morbidity in Patients with Psoriatic Arthritis: A Meta-Analysis of Observational Studies. Arthritis Care Res (Hoboken), 69(1), 67–74. doi: 10.1002/acr.22926.
Daudén, E., Castañeda, S., Suárez, C., García-Campayo, J., Blasco, A. J., Aguilar, M. D., et al. (2013) Clinical practice guideline for an integrated approach to comorbidity in patients with psoriasis. JEADV, 27, 1387–1404. doi: 10.1111/jdv.12024.
Ragozin, R. O. (2014) Biologicheskie ritmy arterial´nogo davleniya u bol´nykh psoriazom [Biological blood pressure rhythm in psoriasis persons]. Zdorov'e i obrazovanie v XXI veke, 12, 1–4. [in Russian].
(2013) 2013 ESH/ESC Guidelines for the management of arterial hypertensionю J. Hypertens, 31(7), 1281–1357.
(2016) Unifikovanyi klinichnyi protokol pervynnoi, vtorynnoi, tretynnoi medychnoi dopomohy “Psorias, vkliuchaiuchy psoriatychni artropatii”. [Unified clinical protocol of the primary, secondary and tertiaty medical aid “Psoriasis including psoriatic arthropathies”]. Kyiv. [in Ukrainian].
Sirenko, Yu. M. (2011) Hipertonichna khvoroba i arterialni hipertenzii. [Essential hypertension and arterial hypertensions]. Donetsk. [in Ukrainian].
Downloads
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)
